The gene deleted in liver cancer-1 (DLC-1) is located on human chromosome 8p21-22, a region thought to harbor tumor suppressor genes on the basis of its frequent deletion or loss of heterozygosity in a variety of human cancers, including hepatocellular carcinoma (HCC). Deletion or altered expression of DLC-1 is common in HCC. In the current study, the subcellular localization of Dlc-1 protein was determined by immunostaining with antibody to DLC-1 and the possible tumor growth suppressor activity of DLC-1 was investigated by examining the effects of of DLC-1 cDNA transfection in two human HCC cell lines lacking expression of the endogenous gene. The results show that Dlc-1protein is localized in the cell cytoplasm, and the restoration of DLC-1 expression in HCC cells resulted in caspase-3-mediated apoptosis, inhibition of cell growth and invasiveness in vitro as well as in reduction of the ability of the cells to form tumors in athymic nude mice. These observations thus support the notion that Dlc-1 protein is involved in hepatocarcinogenesis and has oncosuppressive activity in HCC.
Introduction
Hepatocellular carcinoma (HCC), is one of the most common cancer worldwide with an estimated over 560 000 new cases annually, most of them fatal. The progression to HCC is a slow process evolving through distinct stages associated with cumulative genomic alterations (Thorgeirsson and Grisham, 2002) . The identification of genes that contribute to the development of HCC is critical to the understanding of molecular mechanisms of hepatocarcinogenesis. Chromosomal regions that are frequently deleted in cancer are thought to be the loci of tumor suppressor genes, whose loss or inactivation allows unrestricted cell proliferation.
The human deleted in liver cancer-1 (DLC-1) gene that was isolated from a primary human HCC (Yuan et al., 1998) . DLC-1 cDNA encodes a 1083-amino-acid protein that is 92.5% identical to the rat p122-RhoGAP (Homma, 1995; Yuan et al., 1998) . The Rho proteins, members of the Ras superfamily are involved in regulation of diverse cellular functions and in the development of various disorders. RhoGAPs (GTPaseactivating proteins) are one of the major classes of regulators of Rho GTPases that convert the active, GTP-bound form of Rho to the inactive, GDP-bound form. RhoGAPs are critical in cell actin cytoskeleton organization, regulation of transcription and cell cycle, control of and membrane trafficking, apoptosis as well as contribute to oncogenic transformation, cancer progression, and tumor metastasis (Boettner and Van Aelst, 2002; Jaffe and Hall, 2002; Peck et al., 2002; Toksoz and Merdek, 2002; Moon and Zheng, 2003; Soccio and Breslow, 2003) .
DLC-1 contains RhoGAP domain and at least two other potential functional motifs, a sterile alpha motif (SAM) domain related to p73/p63 and a StAR-related lipid-transfer (START) domain (Ponting and Aravind, 1999) . In vitro experiments identified two signaling functions for rat DLC-1, activation of phospholipase C-d1 and RhoGAP activity for Rho have been identified (Sekimata et al., 1999) . The rat DLC-1 transfection results in a rapid increase in intracellular Ca 2 þ due to activation of phospholipase C-d1 (Sekimata et al., 1999) . Loss of actin stress fibers and the detachment of cultured cells from the substrate due to DLC-1 overexpression occur in transfected cells, thus, implicating DLC-1 in the signal transduction pathways that regulate cell morphology and adhesion (Sekimata et al., 1999) . RhoGAP activity appears to be solely responsible for this cell response (Sekimata et al., 1999) . SAM and START domains could play a role at physiological expression level DLC-1 but are not required for cytoskeleton organization (Soccio and Breslow, 2003) .
The localization of DLC-1 gene to chromosome 8p21-22, a region of loss of heterozygosity (LOH) in a variety of human cancers raised the possibility that this gene might be frequently targeted in cancer cells. Both microsatellite analyses for LOH and comparative genomic hybridization (CGH) for detection of loss DNA copy number showed that the short arm of chromosome 8, including the locus of DLC-1, is one of the most commonly affected genomic region in HCC (Yuan et al., 1998) . This is reflected in high frequencies of homozygous or heterozygous deletions of DLC-1 found in primary HCC specimens and HCC cell lines. In normal adult tissue the DLC-1 is widely expressed, but in HCC its expression is either low or absent primarily because of genomic deletion and promoter hypermethylation (Yuan et al., 1998 (Yuan et al., , 2003a Ng et al., 2000; Wilson et al., 2000) .
Despite this evidence implicating DLC-1 alterations in HCC, however, the potential role of the encoded protein in the pathogenesis and tumorigenicity of HCC was not explored. We have now investigated the effects of ectopic DLC-1 expression in HCC cell lines lacking expression of the endogenous gene. Restoration of DLC-1 expression in HCC resulted in the induction of apoptosis,impaired cell proliferation and invasiveness in vitro and in vivo tumorigenicity.
Results

DLC-1 expression in HCC cell lines
Both the Focus and 7703K cell lines used in the present study have been characterized previously by CGH, conventional fluorescence in situ chromosome hybridization, Southern blot analysis, Northern blot analysis, and reverse transcription-polymerase chain reaction (RT-PCR) (Yuan et al., 1998; Keck et al., 1999; Zimonjic et al., 1999) . Consistent with the results obtained by Southern blot analysis, the CGH profiles revealed loss of DNA copy number for the short arm of chromosome 8 (where DLC-1 is located) in Focus cells but not in 7703K cells . In both cell lines, DLC-1 expression was undetectable by Northern blot analysis and RT-PCR (Yuan et al., 1998) (Figure 1 ). The DLC-1 silencing was due to heavy hypermetylation of the promoter region in 7703K cells and partial methylation in Focus cells. The hypermethylation status was reversed by the treatment with 5-aza-2 0 -deoxycytidine in 7703K cells (Yuan et al., 2003a) . DLC-1 mRNA was detected by RT-PCR in both Focus and 7703K cells that had been stably transfected with pcDNA3.1 containing a full-length DLC-1 cDNA ( Figure 1 ).
Subcellular distribution of DLC-1
We determined the subcellular localization of DLC-1 in Focus and 7703K cells transfected with pcDNA3.1-DLC-1 by immunofluorescence staining. SK-Hep-1 cells, in which DLC-1 mRNA is abundant (Yuan et al., 1998) , were also examined as a positive control. Immunofluorescent signal distribution clearly showed that DLC-1 was present in the cytoplasm of SK-Hep-1 cells as well as of Focus and 7703K cells expressing the Dlc-1 protein (Figure 2a , i, k). Focus and 7703K cells transfected with the empty vector were negative for DLC-1 immunostaining (Figure 2e, g ).
Cell growth in vitro and cell cycle progression
To determine the effects of restoration of DLC-1 expression in Focus and 7703K cells, we first examined cell growth in vitro. Consistent with previous results of other researchers, expression of DLC-1 resulted in a marked inhibition of the time-dependent increase in the number of viable cells compared with that apparent in cells transfected with the empty vector ( Figure 3 ) (Ng et al., 2000) . This inhibition of cell growth was slightly more pronounced in 7703K cells than in Focus cells. We next examined the possible effect of DLC-1 expression on the cell cycle by flow cytometric analysis. 
Induction of apoptosis by DLC-1 expression
To investigate further the effect of DLC-1 expression on apoptosis, we determined the proportion of apoptotic Focus and 7703K cells after transfection with pcDNA3.1-DLC-1 or with the empty vector. Analysis of cell permeability to YO-PRO-1 and propidium iodide (PI) by flow cytometry revealed that the proportion of apoptotic cells was approximately doubled by expression of DLC-1 (Figure 4c ). Confocal microscopy of cells stained with PI confirmed that DLC1 expression increased the proportion of cells with nuclei exhibiting the chromatin condensation characteristic of apoptosis (Figure 4b ).
To investigate the molecular mechanism of DLC-1-induced apoptosis, we examined the expression of caspase-3, Bcl-2, and Bax by immunoblot analysis. The level of both caspase-3 and Bcl-2 protein was reduced in both 7703K and Focus cells expressing DLC-1 compared with that in the corresponding cells transfected with the empty vector (Figure 4d ). Apparently, Bax protein levels were uniform in all samples (Figure 4d ). (Table 1 ). The rest of the mice developed tumors that were substantially smaller( as much as B50% smaller, Po0.001, Student's test), compared to those formed by empty vector-transfected cells (Table 1) . Representative examples are shown in Figure 6 .
Discussion
In this study we have demonstrated that Dlc-1 protein is localized on the cell cytoplasm and its ectopic expression in HCC cell lines that have lost expression of the endogenous gene resulted in the inhibition of cell growth and migration in vitro, the induction of apoptosis, and a reduction of tumorigenicity in vivo. In the apoptotic program the cytotoxic stimuli activate caspases by initiating signaling pathways converging on the Bcl-2 family of protein (Gross et al., 1999) . The balance between members of this family regulates cell death by controlling mitochondrial membrane permeability and thus the release of proteins that promote cell death (Huang and Strasser, 2000) . Within few days after transfection and retrieval of DLC-1 expression, induction of apoptosis associated with cleavage of caspase-3 and a reduced level of Bcl-2, an antiapoptotic regulator mitochondrial mediator of apoptosis was detected in both HCC cell lines. The balance between Bcl-2 and Bax helps determine cell survival or death following apoptotic stimulus (Oltvai et al., 1993) . The level of Bcl-2 protein expression was reduced in DLC-1-transfected cells, while low presence of the Bax was seemingly equal DLC-1 transfectants and controls. The decreases in procaspase-3 expression in both HCC cell lines suggest that DLC-1 transfer activated caspase-3-mediated apoptosis. The precise mechanism(s) that is involved in the induction of apoptosis after restoration of the DLC-1 expression in HCC and other types of tumor cells remains to be elucidated. Our results showing that restoration of DLC-1 expression in HCC cells inhibited both cell invasiveness in vitro and tumorigenic potential in vivo are consistent with our previous observations with breast cancer cells (Yuan et al., 2003b) . In contrast to our results with breast cancer cells, however, the restoration of DLC-1 expression in HCC cells did not prevent the development of tumors in most injected athymic nude mice; rather, it reduced the size of the resulting tumors. On the basis both of the complete inhibition of tumorigenicity of two metastatic breast cancer cell lines suggested that inactivation of DLC-1 occurs during the metastatic process (Yuan et al., 2003b) . In two isogenic breast cancer cell lines with diametrically opposite metastatic capabilities, DLC-1 was found downregulated in the metastatic relative to the nonmetastatic cells (Euer et al., 2002) . Furthermore, in a similar model, DLC-1 was downregulated in cell populations highly metastatic to bone and not in population weakly metastatic to adrenal gland . Our observations with the inhibition of cell migration of HCC cells through the matrigel by DLC-1 are highly relevant to the process of tumor cell dissemination, the major cause of cancer death.
A high frequency of LOH for chromosomal markers located in the vicinity of DLC-1 has been detected in HCC but not in dysplastic liver nodules (Kahng et al., 2003) . Loss of chromosome 8p has also been associated with metastasis in various models of HCC with a high or low metastatic potential (Qin et al., 1999; Qin et al., 2001) . Although the Focus and 7703K HCC cell lines used in the present study grow rapidly in culture, they are not derived from metastases (He et al., 1984) . Cell lines derived from metastatic HCC would be useful for determining the effect of DLC-1 on tumorigenicity.
The gene DLC-2 was also recently shown to be homologous to DLC-1, to be underexpressed in HCC, and to inhibit Ras-induced transformation of rodent cells (Ching et al., 2003) .These results clearly indicate that Rho-GAP protein has growth inhibitory and antineoplastic effect in the early stages in neoplastic transformation. The negative regulatory activity of Rho-GAP proteins on cell growth is thought to be attributable to their ability to downregulate the GTPase activity of Rho family proteins. Conversely, guanine nucleotide exchange factors (GEFs) may promote cell growth by activating Rho family proteins (Moon and Zheng, 2003) . Rho-GAP domain of the DLC-1 and two other homologous genes is very likely to be associated with the inhibitory effect on tumor cells proliferation.The ability of DLC-1 to suppress the growth of different types of tumors suggests a potential clinical application in the treatment of such cancers.
Materials and methods
Cell lines and culture
Two human HCC cell lines, Focus and 7703K were used in all experiments. The cells were maintained under a humidified atmosphere of 5% CO 2 at 371C in a mixture of Dulbecco's modified Eagle's medium and F-12 (DMEM-F12) supplemented with 10% fetal bovine serum, 2 mM glutamine, penicillin (100 U/ml), and (100 mg/ml), and were subcultured by exposure to trypsin.
Plasmid construction and cell transfection
A full-length DLC-1 cDNA was subcloned into the pcDNA3.1 (Invitrogen, Carlsbad, CA, USA) and pEGFP C3 (Clontech, Palo Alto, CA, USA) vectors, the latter of which was used for expression of DLC-1 fused to the COOH-terminus of enhanced green fluorescent protein (GFP). The sequence and orientation of the vector inserts were confirmed by DNA sequencing and restriction enzyme digestion. Cells were transfected with the vectors with the use of LipofectAmine 2000 (Invitrogen), subjected to selection 48 h after transfection by incubation in complete medium containing G418 (250 mg/ ml) (Invitrogen). Expression of the DLC-1 cDNA in the transfected cell lines was assessed by RT and PCR analysis. The forward primer (CTCGCGAACAAGGGATTATG) in exon 2 and reverse primer (ACACAGCCCAGCCACATTA) in exon 3 were used, which amplified a fragment 507 bp. Selected stable transfectants were expanded and used for subsequent analyses.
Subcellular localization of DLC-1
For immunostaining, cells transfected with either pcDNA3.1-DLC-1 or the empty vector were seeded in four-well chamber slides. After reaching B80% confluence, the cells were fixed with 4% paraformaldehyde and incubated at room temperature first for 1 h with a 1 : 250 dilution of mouse monoclonal antibodies to DLC-1 (BD Transduction Laboratories, Palo Alto, CA, USA) and then for 45 min with a 1 : 1000 dilution of goat anti-mouse IgG1-fluorescein isothiocyanate (FITC)-conjugated, secondary antibodies (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA). Slides were mounted in medium containing 4 0 ,6-diamidino-2-phenylindole (DAPI) (Vector, Burlingame, CA, USA) and examined by fluorescence microscopy.
Cell growth in vitro and cell cycle analysis
Exponentially growing cells were transfected with either pcDNA3.1 or pcDNA3.1-DLC-1, harvested 2 days later, and transferred to six-well plates (3 Â 10 4 cells per well) in G418 selection medium. The cells were collected by trypsinization at 48-h intervals for 10 days, and the number of viable cells was determined by staining with trypan blue. For cell cycle analysis, cells were fixed in ice-cold 70% ethanol 24 h after transfection, isolated by centrifugation, and incubated for 30 min at room temperature with PI (25 mg/ml) in the presence of RNase A (30 mg/ml). The cells were then analysed for DNA content by flow cytometry (manual gating) with a BectonDickinson FACSort; data were analysed with CellQuest software.
Detection of apoptotic cells
Cells were harvested 24 h after transfection with pcDNA3.1-DLC-1 or the empty vector, washed twice in ice-cold phosphate-buffered saline, and processed for the detection of apoptosis (on the basis of increased membrane permeability) with a Two-Color Vybrant Apoptosis Kit (Molecular Probes, Eugene, OR, USA). The nucleic acid stain YO-PRO-1 (green fluorescence) selectively passes through the plasma membrane of apoptotic cells, whereas necrotic cells are stained with PI (red fluorescence). Viable cells are not appreciably stained by either YO-PRO-1 or PI. These three populations of cells were discriminated by flow cytometry.
Apoptosis was also confirmed morphologically. The transfected cells were fixed in ice-cold 70% ethanol, separated by centrifugation, and incubated for 20 min at room temperature with RNase A (30 mg/ml). The cells were then exposed to PI (50 mg/ml) for 30 min at 41C, transferred to slides, and mounted with fluorescent mounting medium (DAKO, Carpinteria, CA, USA). Apoptotic bodies were then detected with a confocal microscope (Bio-Rad MRC 1024).
Immunoblot analysis
At 24 h after transfection with pcDNA3.1-DLC-1 or the empty vector, cells were lysed for 30 min on ice in a solution containing 50 mM Tris-HCl (pH 8.0), 120 mM NaCl, 0.5% NP-40, and protease inhibitors. The protein concentration of the lysate was determined with the Bio-Rad protein assay (Hercules, CA, USA), and 50 mg of lysate protein were then subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis on a 4-20% gradient gel (Invitrogen, Carlsbad, CA, USA).The separated proteins were transferred electrophoretically to a nitrocellulose membrane (Invitrogen, Carlsbad, CA, USA),which was then subjected to immunoblot analysis with antibodies to caspase-3, to Bax, or to Bcl-2 (Santa Cruz Biotechnology, Santa Cruz, CA, USA); equal loading of samples was verified with antibodies to b-actin (Santa Cruz Biotechnology, Santa Cruz, CA, USA). Immune complexes were detected with an ECL kit (Amersham, Arlington Heights, IL, USA).
Cell invasion in vitro
The invasiveness of cells in vitro was determined 24 h after seeding 2 Â 10 5 cells of stable DLC-1 and vector only transfectants in serum-free medium into the upper compartment of BIO-COAT invasion chambers containing a membrane (pore size, 8 mm) that had been coated with matrigel (Becton Dickinson, Bedford, MA, USA). The lower compartment of the chambers contained complete medium. After incubation of the chambers for 22 h at 371C under 5% CO 2 , cells that had migrated to the bottom surface of the membrane were fixed, stained with Diff-Quick (Dade Behring, Newark, DE, USA), and counted.
In vivo tumorigenicity
Cells stably transfected with pcDNA3.1-DLC-1 or the empty vector were harvested and cell viability was determined, after which 2 Â 10 6 viable cells were injected subcutaneously at the proximal dorsal midline of 3-4-week-old female athymic nu/nu mice (Harlan). Tumor size was subsequently measured in two dimensions twice a week.
Statistics
All data are representative of at least three independent experiments. The significance of differences between means was determined by Student's t-test. A P-value of o0.05 was considered statistically significant.
Abbreviations DLC-1, deleted in liver cancer-1; HCC, hepatocellular carcinoma; GFP, green fluorescent protein; RT-PCR, reverse transcription-polymerase chain reaction; DAPI, 4 0 6-diamidino-2-phenylindole; FITC, fluorescein isothiocyanate; PI, propidium iodide; CGH, comparative genomic hybridization.
